Antithrombotic Drugs - Global Market Outlook (2016-2022)

  • ID: 4428372
  • Report
  • Region: Global
  • 184 pages
  • Stratistics Market Research Consulting Pvt Ltd
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

1 of 4

FEATURED COMPANIES

  • Abbott laboratories
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Dr. Reddy’s Laboratories
  • Eli Lilly and Company
  • Pfizer Inc.
  • MORE

The rising prevalence of chronic diseases associated with thrombotic disease requires long-term administration of antithrombotic drugs, which is the key factor enhancing the demand for the antithrombotic drugs market. Furthermore, a growing geriatric population, increasing hereditary diseases, lack of physical activity, increasing awareness among patients about life-threatening diseases, changing lifestyles and increasing hypertension are the factors favouring market growth. However, off- patented drugs, post-operative bleeding and the availability of generic antithrombotic drugs would restrict the antithrombotic drugs market growth. Furthermore, new product launches by key vendors, an up-grade in the antithrombotic drugs and recent R&D programs by major players to develop new drugs are the key opportunities for the market.

Asia Pacific is expected to grasp major revenue and volume share in antithrombotic drugs market and is expected to grow with a high CAGR during the forecast period. This growth is attributed to increasing patient population in China and India. North America and Europe regions have significant penetration of antithrombotic drugs due to continual R&D activities for new drug development and high prevalence rate of cardiac and cancer diseases.

Some of the key global players in antithrombotic drugs market are Bayer AG, Johnson & Johnson Services Inc., Sanofi, Boehringer Ingelheim GmbH, Pfizer Inc., Abbott laboratories, Dr. Reddy’s Laboratories, Pharmacia Inc., Eli Lilly and Company, The Medicines Company, Genentech Inc., Bristol-Myers Squibb., Watson laboratories inc, Zydus pharmaceuticals Inc. and Otsuka.

Drug Types Covered:

  • Anticoagulant
  • Thrombolytic drugs
  • Antiplatelet

Drug Classes Covered:

  • Edoxaban
  • Fondaparinux
  • Heparin
  • Apixaban
  • Debigatran
  • Rivaroxaban

Indications Covered:

  • Myocardial infarction (MI)
  • Venous thromboembolism (VTE)
  • Stroke
  • Acute coronary syndrome (ACS)
  • Peripheral arterial occlusion (PAO)
  • Other Indications

Route of Administration Covered:

  • Oral route
  • Parenteral route

Applications Covered:

  • Blood clot prevention
  • Hyperlipidemia treatment
  • Prophylactic treatment
  • Thromboembolic disease treatment
  • Other Applications

Distribution Channels Covered:

  • Hospital Pharmacies
  • Online Retailers
  • General Pharmacies
  • Drug Stores

Regions Covered:

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • Rest of Asia Pacific
  • Rest of the World
  • Middle East
  • Brazil
  • Argentina
  • South Africa
  • Egypt

What The Report Offers:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott laboratories
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Dr. Reddy’s Laboratories
  • Eli Lilly and Company
  • Pfizer Inc.
  • MORE
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Antithrombotic Drugs Market, By Drug Type
5.1 Introduction
5.2 Anticoagulant
5.3 Thrombolytic drugs
5.4 Antiplatelet

6 Global Antithrombotic Drugs Market, By Drug Class
6.1 Introduction
6.2 Edoxaban
6.3 Fondaparinux
6.4 Heparin
6.5 Apixaban
6.6 Debigatran
6.7 Rivaroxaban

7 Global Antithrombotic Drugs Market, By Indication
7.1 Introduction
7.2 Myocardial infarction (MI)
7.3 Venous thromboembolism (VTE)
7.4 Stroke
7.5 Acute coronary syndrome (ACS)
7.6 Peripheral arterial occlusion (PAO)
7.7 Other Indications

8 Global Antithrombotic Drugs Market, By Route of Administration
8.1 Introduction
8.2 Oral route
8.3 Parenteral route

9 Global Antithrombotic Drugs Market, By Application
9.1 Introduction
9.2 Blood clot prevention
9.3 Hyperlipidemia treatment
9.4 Prophylactic treatment
9.5 Thromboembolic disease treatment
9.6 Other Applications

10 Global Antithrombotic Drugs Market, By Distribution Channel
10.1 Introduction
10.2 Hospital Pharmacies
10.3 Online Retailers
10.4 General Pharmacies
10.5 Drug Stores

11 Global Antithrombotic Drugs Market, By Geography
11.1 North America
11.1.1 US
11.1.2 Canada
11.1.3 Mexico
11.2 Europe
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 UK
11.2.5 Spain
11.2.6 Rest of Europe
11.3 Asia Pacific
11.3.1 Japan
11.3.2 China
11.3.3 India
11.3.4 Australia
11.3.5 New Zealand
11.3.6 Rest of Asia Pacific
11.4 Rest of the World
11.4.1 Middle East
11.4.2 Brazil
11.4.3 Argentina
11.4.4 South Africa
11.4.5 Egypt

12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies

13 Company Profiling
13.1 Bayer AG
13.2 Johnson & Johnson Services Inc.
13.3 Sanofi
13.4 Boehringer Ingelheim GmbH
13.5 Pfizer Inc.
13.6 Abbott laboratories
13.7 Dr. Reddy’s Laboratories
13.8 Pharmacia Inc.
13.9 Eli Lilly and Company
13.10 The Medicines Company
13.11 Genentech Inc.
13.12 Bristol-Myers Squibb.
13.13 Watson laboratories inc
13.14 Zydus pharmaceuticals Inc.
13.15 Otsuka

List of Tables

Table 1 Global Antithrombotic Drugs Market Outlook, By Region (2014-2022) ($MN)
Table 2 Global Antithrombotic Drugs Market Outlook, By Drug Type (2014-2022) ($MN)
Table 3 Global Antithrombotic Drugs Market Outlook, By Anticoagulant (2014-2022) ($MN)
Table 4 Global Antithrombotic Drugs Market Outlook, By Thrombolytic drugs (2014-2022) ($MN)
Table 5 Global Antithrombotic Drugs Market Outlook, By Antiplatelet (2014-2022) ($MN)
Table 6 Global Antithrombotic Drugs Market Outlook, By Drug Class (2014-2022) ($MN)
Table 7 Global Antithrombotic Drugs Market Outlook, By Edoxaban (2014-2022) ($MN)
Table 8 Global Antithrombotic Drugs Market Outlook, By Fondaparinux (2014-2022) ($MN)
Table 9 Global Antithrombotic Drugs Market Outlook, By Heparin (2014-2022) ($MN)
Table 10 Global Antithrombotic Drugs Market Outlook, By Apixaban (2014-2022) ($MN)
Table 11 Global Antithrombotic Drugs Market Outlook, By Debigatran (2014-2022) ($MN)
Table 12 Global Antithrombotic Drugs Market Outlook, By Rivaroxaban (2014-2022) ($MN)
Table 13 Global Antithrombotic Drugs Market Outlook, By Indication (2014-2022) ($MN)
Table 14 Global Antithrombotic Drugs Market Outlook, By Myocardial infarction (MI) (2014-2022) ($MN)
Table 15 Global Antithrombotic Drugs Market Outlook, By Venous thromboembolism (VTE) (2014-2022) ($MN)
Table 16 Global Antithrombotic Drugs Market Outlook, By Stroke (2014-2022) ($MN)
Table 17 Global Antithrombotic Drugs Market Outlook, By Acute coronary syndrome (ACS) (2014-2022) ($MN)
Table 18 Global Antithrombotic Drugs Market Outlook, By Peripheral arterial occlusion (PAO) (2014-2022) ($MN)
Table 19 Global Antithrombotic Drugs Market Outlook, By Other Indications (2014-2022) ($MN)
Table 20 Global Antithrombotic Drugs Market Outlook, By Route of Administration (2014-2022) ($MN)
Table 21 Global Antithrombotic Drugs Market Outlook, By Oral route (2014-2022) ($MN)
Table 22 Global Antithrombotic Drugs Market Outlook, By Parenteral route (2014-2022) ($MN)
Table 23 Global Antithrombotic Drugs Market Outlook, By Application (2014-2022) ($MN)
Table 24 Global Antithrombotic Drugs Market Outlook, By Blood clot prevention (2014-2022) ($MN)
Table 25 Global Antithrombotic Drugs Market Outlook, By Hyperlipidemia treatment (2014-2022) ($MN)
Table 26 Global Antithrombotic Drugs Market Outlook, By Prophylactic treatment (2014-2022) ($MN)
Table 27 Global Antithrombotic Drugs Market Outlook, By Thromboembolic disease treatment (2014-2022) ($MN)
Table 28 Global Antithrombotic Drugs Market Outlook, By Other Applications (2014-2022) ($MN)
Table 29 Global Antithrombotic Drugs Market Outlook, By Distribution Channel (2014-2022) ($MN)
Table 30 Global Antithrombotic Drugs Market Outlook, By Hospital Pharmacies (2014-2022) ($MN)
Table 31 Global Antithrombotic Drugs Market Outlook, By Online Retailers (2014-2022) ($MN)
Table 32 Global Antithrombotic Drugs Market Outlook, By General Pharmacies (2014-2022) ($MN)
Table 33 Global Antithrombotic Drugs Market Outlook, By Drug Stores (2014-2022) ($MN)
Table 34 North America Antithrombotic Drugs Market Outlook, By Country (2014-2022) ($MN)
Table 35 North America Antithrombotic Drugs Market Outlook, By Drug Type (2014-2022) ($MN)
Table 36 North America Antithrombotic Drugs Market Outlook, By Anticoagulant (2014-2022) ($MN)
Table 37 North America Antithrombotic Drugs Market Outlook, By Thrombolytic drugs (2014-2022) ($MN)
Table 38 North America Antithrombotic Drugs Market Outlook, By Antiplatelet (2014-2022) ($MN)
Table 39 North America Antithrombotic Drugs Market Outlook, By Drug Class (2014-2022) ($MN)
Table 40 North America Antithrombotic Drugs Market Outlook, By Edoxaban (2014-2022) ($MN)
Table 41 North America Antithrombotic Drugs Market Outlook, By Fondaparinux (2014-2022) ($MN)
Table 42 North America Antithrombotic Drugs Market Outlook, By Heparin (2014-2022) ($MN)
Table 43 North America Antithrombotic Drugs Market Outlook, By Apixaban (2014-2022) ($MN)
Table 44 North America Antithrombotic Drugs Market Outlook, By Debigatran (2014-2022) ($MN)
Table 45 North America Antithrombotic Drugs Market Outlook, By Rivaroxaban (2014-2022) ($MN)
Table 46 North America Antithrombotic Drugs Market Outlook, By Indication (2014-2022) ($MN)
Table 47 North America Antithrombotic Drugs Market Outlook, By Myocardial infarction (MI) (2014-2022) ($MN)
Table 48 North America Antithrombotic Drugs Market Outlook, By Venous thromboembolism (VTE) (2014-2022) ($MN)
Table 49 North America Antithrombotic Drugs Market Outlook, By Stroke (2014-2022) ($MN)
Table 50 North America Antithrombotic Drugs Market Outlook, By Acute coronary syndrome (ACS) (2014-2022) ($MN)
Table 51 North America Antithrombotic Drugs Market Outlook, By Peripheral arterial occlusion (PAO) (2014-2022) ($MN)
Table 52 North America Antithrombotic Drugs Market Outlook, By Other Indications (2014-2022) ($MN)
Table 53 North America Antithrombotic Drugs Market Outlook, By Route of Administration (2014-2022) ($MN)
Table 54 North America Antithrombotic Drugs Market Outlook, By Oral route (2014-2022) ($MN)
Table 55 North America Antithrombotic Drugs Market Outlook, By Parenteral route (2014-2022) ($MN)
Table 56 North America Antithrombotic Drugs Market Outlook, By Application (2014-2022) ($MN)
Table 57 North America Antithrombotic Drugs Market Outlook, By Blood clot prevention (2014-2022) ($MN)
Table 58 North America Antithrombotic Drugs Market Outlook, By Hyperlipidemia treatment (2014-2022) ($MN)
Table 59 North America Antithrombotic Drugs Market Outlook, By Prophylactic treatment (2014-2022) ($MN)
Table 60 North America Antithrombotic Drugs Market Outlook, By Thromboembolic disease treatment (2014-2022) ($MN)
Table 61 North America Antithrombotic Drugs Market Outlook, By Other Applications (2014-2022) ($MN)
Table 62 North America Antithrombotic Drugs Market Outlook, By Distribution Channel (2014-2022) ($MN)
Table 63 North America Antithrombotic Drugs Market Outlook, By Hospital Pharmacies (2014-2022) ($MN)
Table 64 North America Antithrombotic Drugs Market Outlook, By Online Retailers (2014-2022) ($MN)
Table 65 North America Antithrombotic Drugs Market Outlook, By General Pharmacies (2014-2022) ($MN)
Table 66 North America Antithrombotic Drugs Market Outlook, By Drug Stores (2014-2022) ($MN)
Table 67 Europe Antithrombotic Drugs Market Outlook, By Country (2014-2022) ($MN)
Table 68 Europe Antithrombotic Drugs Market Outlook, By Drug Type (2014-2022) ($MN)
Table 69 Europe Antithrombotic Drugs Market Outlook, By Anticoagulant (2014-2022) ($MN)
Table 70 Europe Antithrombotic Drugs Market Outlook, By Thrombolytic drugs (2014-2022) ($MN)
Table 71 Europe Antithrombotic Drugs Market Outlook, By Antiplatelet (2014-2022) ($MN)
Table 72 Europe Antithrombotic Drugs Market Outlook, By Drug Class (2014-2022) ($MN)
Table 73 Europe Antithrombotic Drugs Market Outlook, By Edoxaban (2014-2022) ($MN)
Table 74 Europe Antithrombotic Drugs Market Outlook, By Fondaparinux (2014-2022) ($MN)
Table 75 Europe Antithrombotic Drugs Market Outlook, By Heparin (2014-2022) ($MN)
Table 76 Europe Antithrombotic Drugs Market Outlook, By Apixaban (2014-2022) ($MN)
Table 77 Europe Antithrombotic Drugs Market Outlook, By Debigatran (2014-2022) ($MN)
Table 78 Europe Antithrombotic Drugs Market Outlook, By Rivaroxaban (2014-2022) ($MN)
Table 79 Europe Antithrombotic Drugs Market Outlook, By Indication (2014-2022) ($MN)
Table 80 Europe Antithrombotic Drugs Market Outlook, By Myocardial infarction (MI) (2014-2022) ($MN)
Table 81 Europe Antithrombotic Drugs Market Outlook, By Venous thromboembolism (VTE) (2014-2022) ($MN)
Table 82 Europe Antithrombotic Drugs Market Outlook, By Stroke (2014-2022) ($MN)
Table 83 Europe Antithrombotic Drugs Market Outlook, By Acute coronary syndrome (ACS) (2014-2022) ($MN)
Table 84 Europe Antithrombotic Drugs Market Outlook, By Peripheral arterial occlusion (PAO) (2014-2022) ($MN)
Table 85 Europe Antithrombotic Drugs Market Outlook, By Other Indications (2014-2022) ($MN)
Table 86 Europe Antithrombotic Drugs Market Outlook, By Route of Administration (2014-2022) ($MN)
Table 87 Europe Antithrombotic Drugs Market Outlook, By Oral route (2014-2022) ($MN)
Table 88 Europe Antithrombotic Drugs Market Outlook, By Parenteral route (2014-2022) ($MN)
Table 89 Europe Antithrombotic Drugs Market Outlook, By Application (2014-2022) ($MN)
Table 90 Europe Antithrombotic Drugs Market Outlook, By Blood clot prevention (2014-2022) ($MN)
Table 91 Europe Antithrombotic Drugs Market Outlook, By Hyperlipidemia treatment (2014-2022) ($MN)
Table 92 Europe Antithrombotic Drugs Market Outlook, By Prophylactic treatment (2014-2022) ($MN)
Table 93 Europe Antithrombotic Drugs Market Outlook, By Thromboembolic disease treatment (2014-2022) ($MN)
Table 94 Europe Antithrombotic Drugs Market Outlook, By Other Applications (2014-2022) ($MN)
Table 95 Europe Antithrombotic Drugs Market Outlook, By Distribution Channel (2014-2022) ($MN)
Table 96 Europe Antithrombotic Drugs Market Outlook, By Hospital Pharmacies (2014-2022) ($MN)
Table 97 Europe Antithrombotic Drugs Market Outlook, By Online Retailers (2014-2022) ($MN)
Table 98 Europe Antithrombotic Drugs Market Outlook, By General Pharmacies (2014-2022) ($MN)
Table 99 Europe Antithrombotic Drugs Market Outlook, By Drug Stores (2014-2022) ($MN)
Table 100 Asia Pacific Antithrombotic Drugs Market Outlook, By Country (2014-2022) ($MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Bayer AG
  • Johnson & Johnson Services Inc.
  • Sanofi
  • Boehringer Ingelheim GmbH
  • Pfizer Inc.
  • Abbott laboratories
  • Dr. Reddy’s Laboratories
  • Pharmacia Inc.
  • Eli Lilly and Company
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll